What is Alzheimer’s?
Seq Biomarque is Addressing an Unmet Need in Alzheimer’s
Alzheimer’s disease is the number one cause of dementia. In the US, approximately 5.5 million people are affected, and the prevalence worldwide is estimated to be as high as 24 million.
Currently, the diagnosis of AD involves Cognitive clinical assessments and the use of expensive (Brain scans) or invasive (spinal fluid) testing.